Literature DB >> 25096995

Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.

Shuangbing Xu1, Xu Li2, Zihua Gong2, Wenqi Wang2, Yujing Li2, Binoj Chandrasekharan Nair2, Hailong Piao2, Kunyu Yang3, Gang Wu3, Junjie Chen4.   

Abstract

Cyclin-dependent kinases (CDKs) are the catalytic subunits of a family of mammalian heterodimeric serine/threonine kinases that play critical roles in the control of cell-cycle progression, transcription, and neuronal functions. However, the functions, substrates, and regulation of many CDKs are poorly understood. To systematically investigate these features of CDKs, we conducted a proteomic analysis of the CDK family and identified their associated protein complexes in two different cell lines using a modified SAINT (Significance Analysis of INTeractome) method. The mass spectrometry data were deposited to ProteomeXchange with identifier PXD000593 and DOI 10.6019/PXD000593. We identified 753 high-confidence candidate interaction proteins (HCIPs) in HEK293T cells and 352 HCIPs in MCF10A cells. We subsequently focused on a neuron-specific CDK, CDK5, and uncovered two novel CDK5-binding partners, KIAA0528 and fibroblast growth factor (acidic) intracellular binding protein (FIBP), in non-neuronal cells. We showed that these three proteins form a stable complex, with KIAA0528 and FIBP being required for the assembly and stability of the complex. Furthermore, CDK5-, KIAA0528-, or FIBP-depleted breast cancer cells displayed impaired proliferation and decreased migration, suggesting that this complex is required for cell growth and migration in non-neural cells. Our study uncovers new aspects of CDK functions, which provide direction for further investigation of these critical protein kinases.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25096995      PMCID: PMC4223486          DOI: 10.1074/mcp.M113.036699

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  64 in total

1.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

2.  Cyclin E is expressed in neurons and forms complexes with cdk5.

Authors:  M Miyajima; H O Nornes; T Neuman
Journal:  Neuroreport       Date:  1995-05-30       Impact factor: 1.837

3.  Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth.

Authors:  L R Zukerberg; G N Patrick; M Nikolic; S Humbert; C L Wu; L M Lanier; F B Gertler; M Vidal; R A Van Etten; L H Tsai
Journal:  Neuron       Date:  2000-06       Impact factor: 17.173

4.  ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl.

Authors:  Hiroko Sato; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Biochim Biophys Acta       Date:  2002-03-19

5.  Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity.

Authors:  S Guidato; D M McLoughlin; A J Grierson; C C Miller
Journal:  J Neurochem       Date:  1998-01       Impact factor: 5.372

6.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.

Authors:  Y Xiong; H Zhang; D Beach
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

7.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.

Authors:  L H Tsai; I Delalle; V S Caviness; T Chae; E Harlow
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

8.  A brain-specific activator of cyclin-dependent kinase 5.

Authors:  J Lew; Q Q Huang; Z Qi; R J Winkfein; R Aebersold; T Hunt; J H Wang
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

9.  A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology.

Authors:  Shigeo Sato; Chieri Tomomori-Sato; Tari J Parmely; Laurence Florens; Boris Zybailov; Selene K Swanson; Charles A S Banks; Jingji Jin; Yong Cai; Michael P Washburn; Joan Weliky Conaway; Ronald C Conaway
Journal:  Mol Cell       Date:  2004-06-04       Impact factor: 17.970

10.  The BioGRID interaction database: 2013 update.

Authors:  Andrew Chatr-Aryamontri; Bobby-Joe Breitkreutz; Sven Heinicke; Lorrie Boucher; Andrew Winter; Chris Stark; Julie Nixon; Lindsay Ramage; Nadine Kolas; Lara O'Donnell; Teresa Reguly; Ashton Breitkreutz; Adnane Sellam; Daici Chen; Christie Chang; Jennifer Rust; Michael Livstone; Rose Oughtred; Kara Dolinski; Mike Tyers
Journal:  Nucleic Acids Res       Date:  2012-11-30       Impact factor: 16.971

View more
  19 in total

1.  CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.

Authors:  Q Wang; J Ma; Y Lu; S Zhang; J Huang; J Chen; J-X Bei; K Yang; G Wu; K Huang; J Chen; S Xu
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

2.  Bi-allelic TMEM94 Truncating Variants Are Associated with Neurodevelopmental Delay, Congenital Heart Defects, and Distinct Facial Dysmorphism.

Authors:  Joshi Stephen; Sateesh Maddirevula; Sheela Nampoothiri; John D Burke; Matthew Herzog; Anju Shukla; Katharina Steindl; Ascia Eskin; Siddaramappa J Patil; Pascal Joset; Hane Lee; Lisa J Garrett; Tadafumi Yokoyama; Nicholas Balanda; Steven P Bodine; Nathanial J Tolman; Patricia M Zerfas; Allison Zheng; Georgia Ramantani; Katta M Girisha; Cecilia Rivas; Pujar V Suresh; Abdel Elkahloun; Hessa S Alsaif; Salma M Wakil; Laila Mahmoud; Rehab Ali; Michaela Prochazkova; Ashok B Kulkarni; Tawfeg Ben-Omran; Dilek Colak; H Douglas Morris; Anita Rauch; Julian A Martinez-Agosto; Stanley F Nelson; Fowzan S Alkuraya; William A Gahl; May Christine V Malicdan
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 3.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

4.  ccd-5, a novel cdk-5 binding partner, regulates pioneer axon guidance in the ventral nerve cord of Caenorhabditis elegans.

Authors:  Abigail H Feresten; Jaffar M Bhat; Alex J Yu; Richard Zapf; Hamida Safi; Vinci Au; Stephane Flibotte; Claudia Doell; Donald G Moerman; Nancy Hawkins; Catharine H Rankin; Harald Hutter
Journal:  Genetics       Date:  2022-04-04       Impact factor: 4.562

5.  FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.

Authors:  Xu Li; Wenqi Wang; Yuanxin Xi; Min Gao; MyKim Tran; Kathryn E Aziz; Jun Qin; Wei Li; Junjie Chen
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

6.  Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients.

Authors:  Sara Chiker; Vincent Pennaneach; Damarys Loew; Florent Dingli; Denis Biard; Fabrice P Cordelières; Simon Gemble; Sophie Vacher; Ivan Bieche; Janet Hall; Marie Fernet
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Proteomic Analysis Reveals a Novel Mutator S (MutS) Partner Involved in Mismatch Repair Pathway.

Authors:  Zhen Chen; Mykim Tran; Mengfan Tang; Wenqi Wang; Zihua Gong; Junjie Chen
Journal:  Mol Cell Proteomics       Date:  2016-04       Impact factor: 5.911

8.  Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.

Authors:  Ruan Yushan; Chen Wenjie; Huang Suning; Dang Yiwu; Zhong Tengfei; Wickramaarachchi Mihiranganee Madushi; Luo Feifei; Zhang Changwen; Wen Xin; Gopaul Roodrajeetsing; Li Zuyun; Chen Gang
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

9.  An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.

Authors:  Kanglai Wei; Zhihua Ye; Zuyun Li; Yiwu Dang; Xin Chen; Na Huang; Chongxi Bao; Tingqing Gan; Lihua Yang; Gang Chen
Journal:  World J Surg Oncol       Date:  2016-02-09       Impact factor: 2.754

10.  CDP138 silencing inhibits TGF-β/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer.

Authors:  Yanwei Lu; Jia Ma; Yan Li; Jing Huang; Sheng Zhang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Gang Wu; Kunyu Yang; Shuangbing Xu
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.